Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

1.98USD
21 Sep 2018
Change (% chg)

$0.08 (+4.21%)
Prev Close
$1.90
Open
$1.92
Day's High
$1.98
Day's Low
$1.92
Volume
1,669
Avg. Vol
3,282
52-wk High
$4.21
52-wk Low
$1.76

Latest Key Developments (Source: Significant Developments)

Cleveland BioLabs reports Q3 ‍net loss per share, excluding minority interests, $0.11
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Cleveland BioLabs Inc :Cleveland BioLabs reports third quarter 2017 financial results and development progress.Q3 revenue $300,000 versus $1.1 million.Cleveland BioLabs Inc - qtrly ‍net loss, excluding minority interests, $0.11 per share​.Cleveland BioLabs -current cash,cash equivalents,short-term investments is expected to fund operations for at least 1 year beyond filing date of form 10-Q​.  Full Article

BRIEF-Cleveland Biolabs Says Received Formal Notification From EMA

* CLEVELAND BIOLABS - RECEIVED DAY 120 REVIEW QUESTIONS FROM EMA REGARDING MARKETING AUTHORIZATION APPLICATION FOR ENTOLIMOD